Skip to content
★ Sign in to follow
GI

GeNOsys, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Miller John W R, was filed 23 Aug 2012.

GeNOsys, Inc.: what insiders have been doing

Every trade that managers of GeNOsys, Inc. disclose to SEC (Form 4) is tracked on this page. GeNOsys, Inc. has had no insider filing for more than a year; the last one goes back to 23 August 2012.

Since 2008, the database holds 7 purchases and 5 sales by insiders of the company.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
19
Thresholds
n/a
Buy Volume
€411,503
7 ops. · all time
Sell Volume
€233,500
5 ops. · all time

Financial data

as of FY 2011

FY ended August 2011 · cache

Last declaration on 23 August 2012
Declarations19 total
  • ▲
    CEOExecutives
    5,000 USD0SEC
    100,000 shares@ US$0.05Common StockSEC:0001548123-12-000283:0
    Canonical exit: 12 Oct 2011 (T+90)
  • ▲
    CEOExecutives
    20,000 USD0SEC
    1,000,000 shares@ US$0.02Common StockSEC:0001548123-12-000283:1
    Canonical exit: 10 Sept 2012 (T+90)
  • ▲
    CTOExecutives
    150,550 USD0SEC
    5,376,784 shares@ US$0.028Common StockSEC:0001548123-12-000285:0
    Canonical exit: 10 Sept 2012 (T+90)
  • ●
    CTOExecutives
    0SEC
    250,000 shares0Common StockSEC:0001548123-12-000132:0
  • ◆
    DirectorExecutives
    0SEC
    8,500,000 shares0Common StockSEC:0001010412-11-000347:0
  • ●
    CEOExecutives
    0SEC
    250,000 shares0Common StockSEC:0001010412-11-000108:0
  • ▲
    CFOExecutives
    109,850 USD0SEC
    3,138,571 shares@ US$0.035Common StockSEC:0001010412-11-000109:0
    Canonical exit: 27 Jan 2011 (T+90)
  • ◆
    CFOExecutives
    4,000 USD0SEC
    200,000 shares@ US$0.02Common StockSEC:0001010412-11-000109:1
  • ▲
    CEOExecutives
    76,250 USD0SEC
    1,525,000 shares@ US$0.05Common StockSEC:0001010412-11-000108:1
    Canonical exit: 30 Sept 2010 (T+90)
  • ▲
    CEOExecutives
    171,100 USD0SEC
    4,888,571 shares@ US$0.035Common StockSEC:0001010412-11-000108:2
    Canonical exit: 27 Jan 2011 (T+90)
  • ▼
    CEOExecutives
    5,000 USD0SEC
    100,000 shares@ US$0.05Common StockSEC:0001010412-11-000108:3
  • ▼
    DirectorExecutives
    129,954 USD0SEC
    5,198,168 shares@ US$0.025Common StockSEC:0001010412-09-000130:0
  • ▼
    DirectorExecutives
    20,046 USD0SEC
    801,832 shares@ US$0.025Common StockSEC:0001010412-09-000130:1
  • ●
    CEOExecutives
    32,330 USD0SEC
    323,300 shares@ US$0.10Common StockSEC:0001010412-08-000224:0
  • ●
    CEOExecutives
    25,000 USD0SEC
    54,348 shares@ US$0.46Common StockSEC:0001010412-08-000224:1
  • ▼
    CEOExecutives
    149,750 USD0SEC
    2,995,000 shares@ US$0.05Common StockSEC:0001010412-08-000171:0
  • ▲
    Chief Financial OfficerExecutives
    11,000 USD0SEC
    220,000 shares@ US$0.05Common StockSEC:0001010412-08-000169:0
    Canonical exit: 30 Jun 2008 (T+90)
  • ▼
    DirectorExecutives
    43,750 USD0SEC
    875,000 shares@ US$0.05Common StockSEC:0001010412-08-000162:0
  • ●
    DirectorExecutives
    0SEC
    1,000,000 shares0Common StockSEC:0001010412-08-000162:1

19 of 19 declarations

About GeNOsys, Inc.

GeNOsys, Inc. is a company listed on the XNAS market. It specializes in developing genomic solutions to enhance healthcare.